Annual Cash & Cash Equivalents
$23.18 M
-$18.61 M-44.53%
31 December 2023
Summary:
Theriva Biologics annual cash & cash equivalents is currently $23.18 million, with the most recent change of -$18.61 million (-44.53%) on 31 December 2023. During the last 3 years, it has risen by +$16.95 million (+272.20%). TOVX annual cash & cash equivalents is now -65.57% below its all-time high of $67.33 million, reached on 31 December 2021.TOVX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$16.41 M
-$184.00 K-1.11%
01 September 2024
Summary:
Theriva Biologics quarterly cash and cash equivalents is currently $16.41 million, with the most recent change of -$184.00 thousand (-1.11%) on 01 September 2024. Over the past year, it has dropped by -$14.75 million (-47.34%). TOVX quarterly cash and cash equivalents is now -78.66% below its all-time high of $76.89 million, reached on 01 March 2021.TOVX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.5% | -47.3% |
| 3 y3 years | +272.2% | -75.6% |
| 5 y5 years | +54.0% | +9.1% |
TOVX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.6% | +272.2% | -75.6% | at low |
| 5 y | 5 years | -65.6% | +272.2% | -78.7% | +173.3% |
| alltime | all time | -65.6% | >+9999.0% | -78.7% | >+9999.0% |
Theriva Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.41 M(-1.1%) |
| June 2024 | - | $16.59 M(-9.1%) |
| Mar 2024 | - | $18.26 M(-21.2%) |
| Dec 2023 | $23.18 M(-44.5%) | $23.18 M(-25.6%) |
| Sept 2023 | - | $31.16 M(-9.0%) |
| June 2023 | - | $34.25 M(-5.1%) |
| Mar 2023 | - | $36.08 M(-13.7%) |
| Dec 2022 | $41.79 M(-37.9%) | $41.79 M(-17.2%) |
| Sept 2022 | - | $50.49 M(-3.4%) |
| June 2022 | - | $52.27 M(-7.8%) |
| Mar 2022 | - | $56.69 M(-15.8%) |
| Dec 2021 | $67.33 M(+981.2%) | - |
| Dec 2021 | - | $67.33 M(-6.7%) |
| Sept 2021 | - | $72.14 M(-2.9%) |
| June 2021 | - | $74.29 M(-3.4%) |
| Mar 2021 | - | $76.89 M(+1134.7%) |
| Dec 2020 | $6.23 M(-58.6%) | $6.23 M(+3.7%) |
| Sept 2020 | - | $6.00 M(-25.5%) |
| June 2020 | - | $8.06 M(-20.1%) |
| Mar 2020 | - | $10.09 M(-33.0%) |
| Dec 2019 | $15.04 M(-48.0%) | $15.04 M(-19.3%) |
| Sept 2019 | - | $18.65 M(-14.1%) |
| June 2019 | - | $21.71 M(-12.1%) |
| Mar 2019 | - | $24.69 M(-14.6%) |
| Dec 2018 | $28.92 M(+69.0%) | $28.92 M(+202.8%) |
| Sept 2018 | - | $9.55 M(+33.9%) |
| June 2018 | - | $7.13 M(-35.4%) |
| Mar 2018 | - | $11.04 M(-35.5%) |
| Dec 2017 | $17.12 M(-10.2%) | $17.12 M(-18.7%) |
| Sept 2017 | - | $21.05 M(+57.4%) |
| June 2017 | - | $13.38 M(-0.7%) |
| Mar 2017 | - | $13.47 M(-29.3%) |
| Dec 2016 | $19.05 M(-8.5%) | $19.05 M(+318.9%) |
| Sept 2016 | - | $4.55 M(-54.7%) |
| June 2016 | - | $10.05 M(-33.5%) |
| Mar 2016 | - | $15.10 M(-27.5%) |
| Dec 2015 | $20.82 M(+18.8%) | $20.82 M(-34.5%) |
| Sept 2015 | - | $31.81 M(+568.6%) |
| June 2015 | - | $4.76 M(-60.5%) |
| Mar 2015 | - | $12.05 M(-31.2%) |
| Dec 2014 | $17.52 M(+19.8%) | $17.52 M(+433.3%) |
| Sept 2014 | - | $3.29 M(-58.1%) |
| June 2014 | - | $7.84 M(-29.7%) |
| Mar 2014 | - | $11.15 M(-23.7%) |
| Dec 2013 | $14.63 M(+46.9%) | $14.63 M(+184.3%) |
| Sept 2013 | - | $5.14 M(-25.2%) |
| June 2013 | - | $6.88 M(-19.3%) |
| Mar 2013 | - | $8.52 M(-14.4%) |
| Dec 2012 | $9.95 M(+49.1%) | $9.95 M(+117.5%) |
| Sept 2012 | - | $4.58 M(-22.8%) |
| June 2012 | - | $5.93 M(-12.8%) |
| Mar 2012 | - | $6.80 M(+1.9%) |
| Dec 2011 | $6.68 M | $6.68 M(+44.9%) |
| Sept 2011 | - | $4.61 M(-45.0%) |
| June 2011 | - | $8.39 M(+37.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $6.08 M(+129.5%) |
| Dec 2010 | $2.65 M(-2.4%) | $2.65 M(-19.9%) |
| Sept 2010 | - | $3.31 M(+1.1%) |
| June 2010 | - | $3.27 M(+65.3%) |
| Mar 2010 | - | $1.98 M(-27.1%) |
| Dec 2009 | $2.71 M(-53.6%) | $2.71 M(-23.1%) |
| Sept 2009 | - | $3.53 M(-20.1%) |
| June 2009 | - | $4.42 M(-16.4%) |
| Mar 2009 | - | $5.29 M(-9.7%) |
| Dec 2008 | $5.86 M(-49.0%) | $5.86 M(-9.0%) |
| Sept 2008 | - | $6.44 M(-13.7%) |
| June 2008 | - | $7.45 M(-14.9%) |
| Mar 2008 | - | $8.76 M(-23.8%) |
| Dec 2007 | $11.49 M(-5.7%) | $11.49 M(+56.3%) |
| Sept 2007 | - | $7.35 M(-19.3%) |
| June 2007 | - | $9.11 M(-16.7%) |
| Mar 2007 | - | $10.94 M(-10.3%) |
| Dec 2006 | $12.19 M(+953.1%) | $12.19 M(+7389.2%) |
| Dec 2005 | $1.16 M(+253.9%) | - |
| Mar 2003 | - | $162.80 K(-50.2%) |
| Dec 2002 | $327.20 K(-61.9%) | $327.20 K(-6.0%) |
| Sept 2002 | - | $348.10 K(-59.3%) |
| June 2002 | - | $855.90 K(-19.0%) |
| Mar 2002 | - | $1.06 M(+23.0%) |
| Dec 2001 | $859.30 K(-71.8%) | $859.30 K(-59.4%) |
| Sept 2001 | - | $2.12 M(+44.7%) |
| June 2001 | - | $1.46 M(-38.5%) |
| Mar 2001 | - | $2.38 M(-21.7%) |
| Dec 2000 | $3.04 M(-21.5%) | $3.04 M(+85.0%) |
| Sept 2000 | - | $1.64 M(-10.9%) |
| June 2000 | - | $1.85 M(-47.1%) |
| Mar 2000 | - | $3.49 M(-10.0%) |
| Dec 1999 | $3.87 M(+55.0%) | $3.87 M(+384.3%) |
| Sept 1999 | - | $800.00 K(-38.5%) |
| June 1999 | - | $1.30 M(-31.6%) |
| Mar 1999 | - | $1.90 M(-24.0%) |
| Dec 1998 | $2.50 M(+525.0%) | $2.50 M(-3.8%) |
| Sept 1998 | - | $2.60 M(-51.9%) |
| June 1998 | - | $5.40 M(+1250.0%) |
| Dec 1997 | $400.00 K(-80.0%) | $400.00 K(-60.0%) |
| Sept 1997 | - | $1.00 M(+100.0%) |
| June 1997 | - | $500.00 K(-83.3%) |
| Mar 1997 | - | $3.00 M(+50.0%) |
| Dec 1996 | $2.00 M(+5.3%) | $2.00 M(-42.9%) |
| Sept 1996 | - | $3.50 M(-32.7%) |
| June 1996 | - | $5.20 M(+160.0%) |
| Mar 1996 | - | $2.00 M(+5.3%) |
| Dec 1995 | $1.90 M(+1800.0%) | $1.90 M(-36.7%) |
| Sept 1995 | - | $3.00 M(+2900.0%) |
| Dec 1994 | $100.00 K(-94.1%) | $100.00 K(-97.7%) |
| Mar 1994 | - | $4.40 M(+158.8%) |
| Dec 1993 | $1.70 M | $1.70 M(-39.3%) |
| Sept 1993 | - | $2.80 M(-33.3%) |
| June 1993 | - | $4.20 M(-8.7%) |
| Mar 1993 | - | $4.60 M |
FAQ
- What is Theriva Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Theriva Biologics?
- What is Theriva Biologics annual cash & cash equivalents year-on-year change?
- What is Theriva Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Theriva Biologics?
- What is Theriva Biologics quarterly cash and cash equivalents year-on-year change?
What is Theriva Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of TOVX is $23.18 M
What is the all time high annual cash & cash equivalents for Theriva Biologics?
Theriva Biologics all-time high annual cash & cash equivalents is $67.33 M
What is Theriva Biologics annual cash & cash equivalents year-on-year change?
Over the past year, TOVX annual cash & cash equivalents has changed by -$18.61 M (-44.53%)
What is Theriva Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TOVX is $16.41 M
What is the all time high quarterly cash and cash equivalents for Theriva Biologics?
Theriva Biologics all-time high quarterly cash and cash equivalents is $76.89 M
What is Theriva Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, TOVX quarterly cash and cash equivalents has changed by -$14.75 M (-47.34%)